Neutrophilia and the production of neutrophil extracellular traps (NETs) are two of many
measures of increased inflammation in severe COVID-19 that also accompany its …

Cardiovascular and cerebrovascular diseases are the number one killer threatening
people's life and health, among which cardiovascular thrombotic events are the most …

Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are two related
autoimmune diseases. In recent years, there has been sufficient evidence to suggest that …

The antiphospholipid syndrome (APS) is an autoimmune and prothrombotic condition
defined by the association of thrombotic events and/or obstetrical complications and the …

An update on inflammation in antiphospholipid syndrome : Current Opinion in Rheumatology An
update on inflammation in antiphospholipid syndrome : Current Opinion in Rheumatology Log in …

Antiphospholipid syndrome (APS) is a systemic autoimmune condition characterised by the
presence of antiphospholipid antibodies (aPL) associated with vascular thrombosis and/or …

Objectives Complement activation has been advocated as one mechanism by which aPLs
can induce thrombosis. In patients with catastrophic APS or re-thrombosis, enhanced …

Background Alterations of the trimethylation of histone 3 lysine 4 (H3K4me3) mark in
monocytes are implicated in the development of autoimmune diseases. Therefore, the …

Antiphospholipid antibody syndrome (APS) is an autoimmune disorder characterised by
thrombosis and the presence of antiphospholipid antibodies (aPL): lupus anticoagulant …

APS is an autoimmune disorder with life-threatening complications that, despite therapeutic
advantages, remains associated with thrombotic recurrences and treatment failure. The role …